Home

Guiding Principles

Staff

Research Projects

Downloadable Documents

Training Programmes

Consultation/Liaison

National Conference

Publications

Matua Raki

Links

ATRIG

Contact Us

National Addiction Centre Peer Reviewed Publications

PUBLISHED


2010

  1. Heather N, Adamson SJ, Raistrick D, Slegg GP on behalf of the UKATT Research Team. Initial preference for drinking goal in the treatment of alcohol problems: I. Baseline differences between abstinence and non-abstinence groups. Alcohol & Alcoholism 2010;45(2):128-135. http://alcalc.oxfordjournals.org/cgi/content/abstract/45/2/128
  2. Adamson SJ, Heather N, Morton V, Raistrick D on behalf of the UKATT Research Team. Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes. Alcohol & Alcoholism 2010;45(2):136-142. http://alcalc.oxfordjournals.org/cgi/content/full/45/2/136
  3. Sellman D, Adamson S, Todd F, Deering D. Science will uncover the mysteries of addiction in the end. Addiction 2010;105:14-21. http://alcoholreports.blogspot.com/2009/12/science-will-uncover-mysteries-of.html
  4. Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, Sellman JD. An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug and Alcohol Dependence 2010;110:137-143.
    http://www.elsevier.com/locate/drugalcdep
  5. Campbell SD, Adamson SJ, Carter JD. Client language during Motivational Enhancement Therapy and alcohol use outcome. Behavioural and Cognitive Psychotherapy 2010;38(4):339-415.



2009

  1. Adamson SJ, Sellman JD, Frampton CMA. Patient predictors of alcohol treatment outcome: A systematic review. Journal of Substance Abuse Treatment 2009;36(1):75-86.
    http://linkinghub.elsevier.com/retrieve/pii/S074054720800086X
  2. Sellman JD, Robinson GM, Beasley R. Should ethanol be scheduled as a drug of high risk to public health? Journal of Psychopharmacology 2009;23(1):94-100.
    http://jop.sagepub.com/cgi/content/short/0269881108091596v1
  3. Durrant R, Adamson S, Todd F, Sellman D. Drug use and addiction: evolutionary perspective. Australian and New Zealand Journal of Psychiatry 2009;43:1049-1056.
    http://dx.doi.org./10.1080/00048670903270449
  4. Schroder R, Sellman D, Frampton C, Deering D. Youth retention: Factors associated with treatment drop-out from youth alcohol and other drug treatment. Drug and Alcohol Review 2009;28:663-668.
    http://www3.interscience.wiley.com/journal/122413760/grouphome/home.html
  5. Adamson SJ & Wells JE. Hazardous drinking: Not just an issue for the minority of drinkers. The New Zealand Medical Journal 2009;122(1306).
  6. Sellman D. The 10 most important things known about addiction. Addiction 2009;105:6-13.
    http://www3.interscience.wiley.com/journal/122579394/abstract

 

2008

  1. Adamson SJ, Sellman JD, Robertson PJ. Social phobia in an outpatient alcohol and drug treatment sample. Australian and New Zealand Journal of Psychiatry 2008;42(2):134-140.
  2. Deering D, Sellman JD, Adamson S, Horn J, Frampton C. Development of a brief treatment instrument for routine clinical use with methadone maintenance treatment clients: The Methadone Treatment Index. Substance Use and Misuse 2008;43:1666-1680.
  3. Adamson S, Sellman JD. Five-year outcomes of alcohol dependent persons treated with motivational enhancement. Journal of Studies on Alcohol and Drugs 2008;69:589-593.
  4. Schroder R, Sellman D, Frampton C, Deering D. Profile of young people attending alcohol and other drug treatment services in Aotearoa, New Zealand: clinical file search. Australian and New Zealand Journal of Psychiatry 2008;42(11):963-968.
  5. Preference Collaborative Review Group. Patients' preferences within randomised trials: A systematic review and individual patient data meta-analysis. BMJ 2008;337;a1864doi:10.1136/bmj.a1864.
    http://www.bmj.com/cgi/content/abstract/337/oct31_1/a1864
  6. Porter RJ, Sellman JD, Joyce PR, Davies J, Frampton CM. Prolactin response to fenfluramine in abstinent, alcohol-dependent patients. Addiction Biology 2008;13(3-4):380-385.


2007

  1. Baker PB, Sellman JD, Horn J. The spiritual characteristics of New Zealanders entering treatment for alcohol/other drug dependence. Alcoholism Treatment Quarterly 2007;24(4):137-155.
  2. Harvey MA, Sellman JD, Porter RJ, Frampton CM. The relationship between non-acute adolescent cannabis use and cognition. Drug and Alcohol Review 2007;26(3):309-319.
  3. Sellman JD, MacEwan I, Deering DEA, Adamson SJ. A comparison of motivational interviewing with non-directive counselling. In Motivational Dialogue: Preparing Addiction Professionals for Motivational Interviewing Practice. G Tober, D Raistrick eds. Routledge (2007) [978-1583912959].
  4. Sellman JD, Baker MP, Adamson SJ, Geering LG. The future of God in recovery from drug addiction. Australian and New Zealand Journal of Psychiatry 2007;41(10):800-808.

2006

  1. Adamson SJ, Todd FC, Sellman JD, Huriwai T, Porter J. Co-existing psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population. Australian and New Zealand Journal of Psychiatry 2006; 40:164-170.
    http://informahealthcare.com/doi/abs/10.1080/j.1440-1614.2006.01764.x
  2. Robertson PJ, Haitana TN, Pitama SG, Huriwai TT. A review of work-force development literature for the Mäori addiction treatment field in Aotearoa/New Zealand. Drug and Alcohol Review May 2006;(25):233-239.
  3. Cape G, Hannah A, Sellman D. A longitudinal evaluation of medical student knowledge, skills and attitudes to alcohol and drugs. Addiction 2006; 101:841-849.
    http://www3.interscience.wiley.com/cgi-bin/fulltext/118730737/HTMLSTART
  4. McCormick R, Sellman D, Robinson G. Where to next with tobacco smokers? The New Zealand Medical Journal 2006. 119(1238): http://www.nzma.org.nz/journal/119-1238/2084/
  5. Chris Bullen, Robyn Whittaker, Natalier Walker, Mark Wallace-Bell. Pre-quitting nicotine replacement therapy: Findings from a pilot study. Tobacco Induced Diseases 2006; 3(2):35-40.
    http://www.tobaccoinduceddiseases.com/content/3/2/35
  6. Adamson S, Sellman D, Deering D, Robertson P, de Zwart K. A profile of the alcohol and drug treatment population in New Zealand; a comparison of 1998 and 2004 data. The New Zealand Medical Journal 2006. 119(1244). http://www.nzma.org.nz/journal/119-1244/
  7. McCormick R, Kalin C, Huriwai T. Alcohol and other drug treatment in New Zealand - one size doesn't fit all. The New Zealand Medical Journal 2006. 119(1244). http://www.nzma.org.nz/journal/119-1244/
  8. Surgenor LJ, Horn J, Hudson SM, Adamson S, Robertson P. Alcohol dependence and psychological sense of control: refining the links. New Zealand Journal of Psychology 2006; 3:145-151.

2005

  1. Robertson PJ, Pitama S, Ahuriri-Driscoll A, Haitana T, Larsen JJ, Utaii S. Developing services in Te Rohe O Ngai Tahu for Mäori with gambling related problems. New Zealand Journal of Psychology 2005; 1:28-36.
  2. Adamson SJ, Sellman JD, Dore GM. Therapy preference and treatment outcome in clients with mild to moderate alcohol dependence. Drug and Alcohol Review 2005; 24(3):209-216.

BACK TO TOP

2004

  1. Rogers G, Joyce P, Mulder R, Sellman D, Miller A, Allington M, Olds R, Wells E, Kennedy M. Association of a duplicated repeat polymorphism in the 5’- untranslated region of the DRD4 gene with novelty seeking. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 2004; 126B:95-98.
  2. Sheerin I, Green T, Sellman D, Adamson S, Deering D. Reduction in crime and imprisonment for injecting drug users on a Methadone Maintenance Programme in New Zealand. The New Zealand Medical Journal 2004; 117(1190): http://www.nzma.org.nz/journal/117-1190/795/.
  3. Lim D, Sellman D. Pathological gambling: neurobiology and pharmacological treatment in Tan RHK and Wurtzburg SJ (Eds) Problem gambling: New Zealand perspectives on treatment. Steele Roberts & Pacific Education Resources Trust 2004, 134-142.
  4. Lim, DK, Mahendran R. A case of megacolon associated with risperidone. Review Series Psychiatry 2004; 1:14-15.
  6. Deering DE, Frampton CMA, Horn J, Sellman JD, Adamson SJ, Potiki TL. Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire. Drug and Alcohol Review 2004; 23(3): 273-280.
  7. Todd F, Sellman D. (2004). Alcohol and drug misuse and mood disorders. In P Joyce and P Mitchell (Eds) Mood Disorders Recognition and Treatment. Sydney: The University of New South Wales Press Ltd 2004.

2003
  1. Sheerin IG, Green FT, Sellman JD. The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand. Drug and Alcohol Review 2003; 22(2): 159-167.
  3. Lim DK. Ketamine associated psychedelic and psychotic effects. Singapore Medical Journal 2003; 44(1): 557-562
  4. Cowan L, Deering DE, Crowe M, Sellman JD, Futterman-Collier A, Adamson S. Alcohol and drug treatment for women: Clinicians' beliefs and practice. International Journal of Mental Health Nursing 2003; 12: 48-55.

2002
  1. Sellman JD, Adamson SJ, Robertson P, Sullivan S, Coverdale J. Gambling in mild-moderate alcohol dependent outpatients. Substance Use and Misuse 2002; 37(2): 199-214.
  2. Robertson P, Huriwai T, Potiki T, Friend R, Durie M. Working with Mäori with alcohol and drug related problems. Chapter 18 in G Hulse, G Cape, J White (Eds) The management of alcohol and other drug problems. Oxford: Oxford University Press 2002.
  3. Sellman JD, Deering DE. Adolescence. Chapter 15 in G Hulse, G Cape, J White (Eds) The management of alcohol and other drug problems. Oxford; Oxford University Press 2002.
  4. Todd F, McLean S, Krum H, Martin J, Copeland J. Cannabis. Chapter 9 in G Hulse, G Cape, J White (Eds) The management of alcohol and other drug problems. Oxford: Oxford University Press 2002.
  5. Todd F. Coexisting alcohol and drug use and mental health disorders. Chapter 20 in G Hulse, G Cape, J White (Eds) The management of alcohol and other drug problems. Oxford: Oxford University Press 2002.
  6. Huriwai T. Re-enculturation; culturally congruent interventions for Mäori with alcohol and drug-use-associated problems in New Zealand. Substance Use and Misuse, Special Issue on the Middle Eastern Summer Institute on Drug Use Proceedings: 1997-1999, 2002 37(8-10): 1259-1268
  7. Huriwai T. Innovative alcohol- and drug-user treatment of inmates in New Zealand prisons. Substance Use and Misuse, Special Issue on the Middle Eastern Summer Institute on Drug Use Proceedings: 1997-1999, 2002 37(8-10): 1035-1045
  8. de Zwart K.M, Sellman JD Public knowledge and attitudes regarding smoking and smoking cessation treatments. The New Zealand Medical Journal 2002, 115(1153): 219-222
  9. Todd FC, Sellman JD, Robertson PJ. Barriers to optimal care for patients with coexisting substance use and mental health disorders. Australian and New Zealand Journal of Psychiatry 2002, 36(6): 792-799
  10. Cape GS, Ivory SJ, Sellman D, Robinson G, Adams P. Evaluation of alcohol and drug education and training in NZ medical students. Focus on Health Professional Education: A Multi-Disciplinary Journal 2002; 4(3): 61-74.
  11. Ng BY, Yap AK, Su A, Lim D, Ong SH. Personality profiles of patients with dissociative trance disorder in Singapore. Comprehensive Psychiatry 2002; 43(2): 121-126
  12. Lim DK, Mahendran R. Risperidone and Megacolon. Singapore Medical Journal 2002;43(8): 423-425

2001

  1. Sellman JD, Sullivan PF, Dore GM, Adamson SJ, MacEwan I. A randomized controlled trial of motivational enhancement therapy (MET) for alcohol dependence. Journal of Studies on Alcohol 2001;62(3):389-396.
  2. Khan N. Wilkinson T, Sellman JD, Graham P. Patterns of alcohol use and misuse among elderly rest home residents in Christchurch. New Zealand Medical Journal 2001;114:58-61.
  3. Robertson P, Futterman-Collier A, Sellman JD, Adamson SJ, Deering D, Todd F, Huriwai T. Clinician beliefs and practices related to increasing responsivity to the needs of Mäori with alcohol and drug problems. Substance Use and Misuse 2001;36(8):1015-1032.
  4. Deering DE, Adamson SJ, Sellman JD, Frampton C, Robertson P. A regional census of high school guidance counsellors: Current and perceived optimal practice in assisting students with alcohol and drug related problems. New Zealand Journal of Educational Studies 2001;36(1):81-92.
  5. Adamson S, Sellman JD. Drinking goal selection and treatment outcome in outpatients with mild to moderate alcohol dependence. Drug and Alcohol Review 2001;20(4):351-359.
  6. Berry R, Sellman JD. Childhood adversity in alcohol and drug dependent women presenting to out-patient treatment. Drug and Alcohol Review 2001;20(4):361-367.
  7. Huriwai T, Armstrong D, Huata P, Kingi J, Robertson P. Whanaungatanga: A process in the Treatment of Mâori with alcohol and drug problems. Substance Use and Misuse 2001; 36(8): 1033-1052.
  8. Townshend PL, Sellman JD, Coverdale JH. A preventive ethics approach to methadone maintenance programmes. New Zealand Bioethics Journal 2001; October: 7-13.
  9. Lim DK. A case of pathological gambling - its features and management. Singapore Medical Journal 2001; 42(5):217-219.
  10. Lee A, Tan S, Lim D, Winslow RM, Wong KE, Allen J, Hall W, Parker G. Naltrexone in the treatment of male alcoholics - an effectiveness study in Singapore. Drug and Alcohol Review 2001; 20:193-199.
  11. Lim KD, Ng KC, Ng SK, Ng LL. Falls amongst institutionalized psycho-geriatric patients. Singapore Medical Journal 2001; 42(9): 417-419.
  12. Yap HL, Mahendran R, Lim D, Liow PH, Lee A, Phang S, Tiong A. Risperidone in the treatment of first episode psychosis. Singapore Medical Journal 2001; 42(4): 170-173.
  13. Wenzel LB, Futterman-Collier AD, Munn NA. Psychosocial Aspects of Cancer. M Wood & PA Bunn (Eds), Hematology/Oncology Secrets, Volume II. Hanley & Belfus, Pennsylvania.

2000

  1. Huriwai T. Comment on indigenous Australians and liquor licensing restrictions. Addiction 2000;95(11):1705-1717.
  2. Huriwai T, Sellman JD, Sullivan P, Potiki T. Optimal treatment for Mäori with alcohol and drug problems: An investigation of the importance of cultural factors in treatment. Substance Use and Misuse 2000; 35(3) : 281-300.
  3. Mancall P, Robertson P. Huriwai T. Mäori and Alcohol. A reconsidered history. Australian and New Zealand Journal of Psychiatry 2000; 129-134.
  4. Adamson SJ, Sellman JD, Futterman-Collier A, Huriwai T, Deering D, Todd F, Robertson P. A profile of alcohol and drug clients in New Zealand: Results from the 1998 national telephone survey. New Zealand Medical Journal 2000; 113:414-416.
  5. Mahendran R, Winslow M, Lim D. Recurrent Neuroleptic Malignant Syndrome. Australian & New Zealand Journal of Psychiatry 2000; 34:699-700.

1999

  1. Robertson P, Larsen J, Hillman D & Hudson S. Conceptual issues in therapy with sexually abusive Mäori men. In AD Lewis (Ed) Cultural diversity in sexual abuser treatment : Issues and approaches. Burlington, Vermont, Safer Society Press 1999 pp 188-214.
  2. Sellman JD, Wootton AR, Stoner DB, Deering DE, Craig BJ. Increasing diagnosis of nicotine dependence in adolescent mental health patients. Australian and New Zealand Journal of Psychiatry; 1999, 33:869-873.
  3. Futterman-Collier, AD, McClure F, Futterman-Collier JH, Otto C, Polloi A. Culture-specific views of child maltreatment and parenting styles in a Pacific Island community. Child Abuse and Neglect 1999; 23:229-244.
  4. Maynard K, Coebergh B, Bakker L. Antiss B, Huriwai T. Ki ta Arotu: Toward a new assessment - the identification of cultural factors that might predispose Mäori to offending. Social Policy Journal of New Zealand 1999; 13:43-58.
  5. Todd F, Sellman JD, Robertson P. The assessment and management of people with co-existing substance use and mental health disorders. 1999, Alcohol Advisory Council, Wellington.

BACK TO TOP

1998

  2. Sullivan PF, Fifield WJ, Kennedy MA, Mulder RT, Sellman JD, Joyce PR. No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples. American Journal of Psychiatry 1998;155:98-101.
  3. Deering DE. Measuring effectiveness of methadone maintenance treatment. In Sellman JD, Robinson GM, McCormick R, Dore GM (Eds): The Long and the Short of Treatment for Alcohol and Drug Disorders. Christchurch, New Zealand: Department of Psychological Medicine, Christchurch School of Medicine 1998 pp 123-128.
  4. Adamson S. The costs of intravenous drug use and associated criminal activity. In Sellman JD, Robinson GM, McCormick R, Dore GM (Eds): The Long and the Short of Treatment for Alcohol and Drug Disorders. Christchurch, New Zealand: Department of Psychological Medicine, Christchurch School of Medicine 1998 PP 105-115.
  5. Todd F. Benzodiazepines and methadone maintenance therapy. In Sellman JD, Robinson GM, McCormick R, Dore GM (Eds): The Long and the Short of Treatment for Alcohol and Drug Disorders. Christchurch, New Zealand: Department of Psychological Medicine, Christchurch School of Medicine 1998 PP 92-104.
  6. Robinson GM, Sellman JD. The use of pharmacological agents in the treatment of alcoholism. In Sellman JD, Robinson GM, McCormick R, Dore GM (Eds): The Long and the Short of Treatment for Alcohol and Drug Disorders. Christchurch, New Zealand: Department of Psychological Medicine, Christchurch School of Medicine 1998 PP 38-44.
  7. Huriwai T, Sant Ram R, Deering DE, Sellman JD. Treatment for Mäori with alcohol and drug problems. In Sellman JD, Robinson GM, McCormick R, Dore GM (Eds): The Long and the Short of Treatment for Alcohol and Drug Disorders. Christchurch, New Zealand: Department of Psychological Medicine, Christchurch School of Medicine 1998 pp 32-37.
  8. Sellman JD. Determinants of alcoholic relapse. In Sellman JD, Robinson GM, McCormick R, Dore GM (Eds): The Long and the Short of Treatment for Alcohol and Drug Disorders. Christchurch, New Zealand: Department of Psychological Medicine, Christchurch School of Medicine 1998 PP 11-23.
  9. Berry R. Alcohol and drug dependent women with a history of childhood sexual abuse. In Sellman JD, Robinson GM, McCormick R, Dore GM (Eds): The Long and the Short of Treatment for Alcohol and Drug Disorders, Christchurch, New Zealand: Department of Psychological Medicine, Christchurch School of Medicine 1998 PP 24-31.
  10. Huriwai T, Sellman JD, Sullivan P, Potiki T. A clinical sample of Mäori being treated for alcohol and drug related problems in New Zealand. New Zealand Medical Journal, 1998;111:145-147.
  11. Larsen J, Robertson P, Hillman D, Hudson S. Te Piriti: A bicultural model for treating child molesters in Aotearoa/New Zealand. In Marshall W, Hudson S, Ward T, Fernandey Y (Eds): Sourcebook of treatment programmes for sexual offenders (PP 385-398). New York:Plenum 1998.

1997

  1. Sullivan PF, Fifield WJ, Kennedy MA, Mulder RT, Sellman JD, Joyce PR. Novelty seeking and a dopamine transporter gene polymorphism (DAT1). Biological Psychiatry, 1997;42:1070-1072.
  2. Sullivan S, McCormick R, Sellman JD. Increased requests for help by problem gamblers: Data from a gambling crisis telephone hotline. New Zealand Medical Journal 1997;110:380-383.
  3. Futterman-Collier A, Sadao K, Otto C, Polloi A. Perceptions of the social, cultural and psychological well-being in Palau, Pacific Health Dialog 1997;4:28-34.
  4. Glover M & Robertson P. Facilitating development of Kaupapa Mäori psychology. In Love H & Whitaker W (Eds): Practice issues for clinical and applied psychologists in New Zealand, Wellington: New Zealand Psychological Society 1997;136-146.
  5. Van Ammers EC, Sellman JD, Mulder RT. Temperament and substance abuse in schizophrenia: Is there a relationship? Journal of Nervous and Mental Diseases 1997;185:283-288.
  6. Sellman JD, Huriwai TT. Harm reduction and the use of alcohol by Mäori. Drug and Alcohol Review 1997;16:85-90.
  7. Sellman JD, Mulder RT, Sullivan PF, Joyce PR. Low persistence predicts relapse in alcohol dependence following treatment. Journal of Studies on Alcohol 1997;58:257-263.
  8. Sellman JD, Huriwai T, Sant Ram R, Deering DE. Cultural linkage: treating Mäori with alcohol and drug problems in dedicated Mäori treatment programmes. Substance Use and Misuse 1997;32:415-424.

1996

  1. Mulder RT, Joyce PR, Sellman JD, Sullivan PF, Cloninger CR. Towards an understanding of defense style in terms of temperament and character. Acta Psychiatrica Scandinavica 1996;93:99-104.
  2. Sellman JD, Joyce PR. Does depression predict relapse in the six months following treatment for men with alcohol dependence? Australian and New Zealand Journal of Psychiatry 1996;30:573-578.
  3. Deering DEA, Sellman JD. An inter-rater reliability study of the Opiate Treatment Index (OTI). Drug and Alcohol Review 1996;15:57-63.
  4. Sellman JD, Ariell G. Public knowledge and attitudes towards the use of alcohol and drinking guidelines. New Zealand Medical Journal 1996;109:337-339.

BACK TO TOP
Department of Psychological Medicine
University of Otago, Christchurch
PO Box 4345, Christchurch 8140, New Zealand
Telephone: +64-3-364-0480
Fax: +64-3-364-1225
Comments to: simon.adamson@otago.ac.nz
Last updated: June 2010